REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanghai Allist Pharmaceuticals Co., Ltd (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Shanghai Allist Pharmaceuticals Co., Ltd Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai Allist Pharmaceuticals Co., Ltd. focuses on the R&D, production and sales of innovative drugs. The company provides innovative drugs targeting small molecules of cancer. The company was founded in 2004, headquartered in Shanghai City, China.

Headquarters
No. 268, Lingxiaohua Road, Zhoupu Town, Pudong New Area, Shanghai
Shanghai; Shanghai; Postal Code: 201318

Contact Details: Purchase the Shanghai Allist Pharmaceuticals Co., Ltd report to view the information.

Website: http://www.allist.com.cn

Basic Information
Total Employees:
Purchase the Shanghai Allist Pharmaceuticals Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Shanghai Allist Pharmaceuticals Co., Ltd report to view the information.
Registered Capital:
Purchase the Shanghai Allist Pharmaceuticals Co., Ltd report to view the information.
Financial Auditors:
Purchase the Shanghai Allist Pharmaceuticals Co., Ltd report to view the information.
Incorporation Date:
March 22, 2004
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
32.17%
Purchase this report to view the information.
8.09%
Purchase this report to view the information.
6.11%
Purchase this report to view the information.
5.69%
Purchase this report to view the information.
3.29%
Subsidiaries
Jiangsu Ailisi Biological Medicine Co., Ltd.
100%
Shanghai Ailisi Marketing Planning Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shanghai Allist Pharmaceuticals Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
87.97%
Total operating revenue
85.63%
Operating profit (EBIT)
180.61%
Net Profit (Loss) for the Period
158.99%
Total assets
36.68%
Total equity
33.35%
Operating Profit Margin (ROS)
15.63%
Net Profit Margin
11.51%
Return on Equity (ROE)
10.61%
Quick Ratio
-1.61%
Cash Ratio
-3.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?